Corcept Therapeutics | CORT - Ebit



金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 4.55B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


Ebit 更改 日
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Aurora Cannabis CAD -35.79M 8.96M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
J&J USD 5.11B 2.3B 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD 6.24B 1.32B 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 3.19M 9.96M 2025-12
Pfizer USD 4.65B 71M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12